Literature DB >> 28474321

Three-Year Follow-Up of Laparoscopic Reduced Port Sleeve Gastrectomy in 808 Consecutive Patients.

Mohammad Al Jarallah1, Radwan Kassir2, Mohab El-Barbari3, Shaaban Ali3, Tarek Debs4, Elie Chouillard5.   

Abstract

BACKGROUND: Sleeve gastrectomy (SG) is a very popular technique for the treatment of morbid obesity. Less and less invasive laparoscopic approaches to SG have been proposed and shown to be safe and feasible.
OBJECTIVES: We developed a reduced port laparoscopic approach to sleeve gastrectomy (RLSG) with the aim to further optimize the advantages of laparoscopy. Preliminary and safety profile of RLSG as well as 3 years weight loss outcome are hereby discussed.
SETTING: University Hospital, Kuwait.
MATERIALS AND METHODS: All patients had morbid obesity with history of failure of conservative treatment. The RLSG procedure was performed using only two skin incisions.
RESULTS: The analyzed population comprised 808 patients, including 642 women and 166 men. Mean age and BMI were 28.34 ± 8.37 and 41.09 ± 6.34, respectively. Mean operative time was 43 ± 20 min (range, 31-185). Mortality was nil. Overall morbidity rate was (4.5%). Three patients had postoperative leak (0.4%). Median duration of hospital stay was 2 days (range, 1-5). Mean percentage of excess weight loss (% EWL) was 23.18 ± 17.3% at 1 month, 55.08 ± 22.9% at 6 months, 82.6 ± 22.6% at 1 year, and 84.3 ± 22.4% at 3 years. Mean percentage total weight loss (%TWL) was 9.34% at 1 month, 22.42% at 6 months, and 34.57% at 1 year.
CONCLUSION: RLSG is a safe and effective surgical option in patients with morbid obesity. Moreover, 3-year follow-up assessment confirmed adequate % EWL.

Entities:  

Keywords:  Gastrectomy; Laparoscopy; Obesity; Sleeve; Surgery

Mesh:

Year:  2017        PMID: 28474321     DOI: 10.1007/s11695-017-2690-x

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  23 in total

1.  C-Reactive protein and procalcitonin for the early detection of postoperative complications after sleeve gastrectomy: preliminary study in 97 patients.

Authors:  R Kassir; P Blanc; L M Bruna Tibalbo; C Breton; P Lointier
Journal:  Surg Endosc       Date:  2014-08-27       Impact factor: 4.584

2.  Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients.

Authors:  Gianfranco Silecchia; Cristian Boru; Alessandro Pecchia; Mario Rizzello; Giovanni Casella; Frida Leonetti; Nicola Basso
Journal:  Obes Surg       Date:  2006-09       Impact factor: 4.129

Review 3.  The long-term effects of bariatric surgery for type 2 diabetes: systematic review and meta-analysis of randomized and non-randomized evidence.

Authors:  Jiajie Yu; Xu Zhou; Ling Li; Sheyu Li; Jing Tan; Youping Li; Xin Sun
Journal:  Obes Surg       Date:  2015-01       Impact factor: 4.129

Review 4.  Single Incision Laparoscopic Sleeve Gastrectomy: a Review.

Authors:  Anastasios Stefanopoulos; Konstantinos P Economopoulos; Vasileios Kalles
Journal:  Obes Surg       Date:  2015-08       Impact factor: 4.129

5.  Single-incision sleeve gastrectomy versus conventional laparoscopic sleeve gastrectomy--a randomised pilot study.

Authors:  Muffazal A Lakdawala; Nor Hisham Muda; Sunita Goel; Aparna Bhasker
Journal:  Obes Surg       Date:  2011-11       Impact factor: 4.129

6.  Laparoscopic bariatric surgery can be performed through a single incision: a comparative study.

Authors:  Tomasz Rogula; Christopher Daigle; Monica Dua; Hideharu Shimizu; Jonathan Davis; Olga Lavryk; Ali Aminian; Philip Schauer
Journal:  Obes Surg       Date:  2014-07       Impact factor: 4.129

7.  Laparoscopic sleeve gastrectomy for morbid obesity.

Authors:  Jason Moy; Alfons Pomp; Gregory Dakin; Manish Parikh; Michel Gagner
Journal:  Am J Surg       Date:  2008-11       Impact factor: 2.565

8.  Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect.

Authors:  Wei-Jei Lee; Keong Chong; Yu-Hung Lin; Jih-Hua Wei; Shu-Chun Chen
Journal:  Obes Surg       Date:  2014-09       Impact factor: 4.129

9.  Roux-en-Y gastric bypass vs sleeve gastrectomy for obese patients with type 2 diabetes: a randomised trial.

Authors:  Andrei Keidar; Karen J Hershkop; Limor Marko; Chaya Schweiger; Lior Hecht; Noam Bartov; Assaf Kedar; Ram Weiss
Journal:  Diabetologia       Date:  2013-06-14       Impact factor: 10.122

10.  A randomized clinical trial of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy for the treatment of morbid obesity in China: a 5-year outcome.

Authors:  Yong Zhang; Hongzhi Zhao; Zhanguo Cao; Xiangyu Sun; Chen Zhang; Wang Cai; Rong Liu; Sanyuan Hu; Mingfang Qin
Journal:  Obes Surg       Date:  2014-10       Impact factor: 4.129

View more
  1 in total

1.  Reduced-port laparoscopic distal gastrectomy in obese gastric cancer patients.

Authors:  Dong Yeon Kang; Ho Goon Kim; Dong Yi Kim
Journal:  PLoS One       Date:  2021-08-05       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.